株価
9.54
毎日の変更
0.19 2.03%
毎月
4.38%
毎年
-11.91%
Q2 予測
9.29




営業経費 変化する 日付
Avita Medical AUD 28.02M 1.55M 2025-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesoblast USD 82.31M 26.16M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Pacific Edge NZD 25.34M 2.03M 2025-12
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12